StockWatch
·
Pharmaceuticals
Business Update14 Jun 2026, 05:00 pm

Kabra Drugs Gets ₹200 Cr Pharma Project LOI from Chhattisgarh

AI Summary

Kabra Drugs Limited has received a Letter of Intent (LOI) from the Government of Chhattisgarh for a ₹200 Crore pharmaceutical manufacturing facility at Nava Raipur Pharma Park. The project aims to expand the company's manufacturing footprint, enhance operational capabilities, and increase production capacity. The facility is expected to generate approximately 250 direct and indirect employment opportunities. This strategic investment aligns with Kabra Drugs' long-term expansion strategy and is subject to definitive agreements and necessary approvals. The company anticipates benefiting from state government policies and incentives.

Key Highlights

  • LOI received for ₹200 Cr pharmaceutical manufacturing project in Chhattisgarh.
  • Project to establish facility at Nava Raipur Pharma Park, expanding manufacturing.
  • Expected to create around 250 direct and indirect employment opportunities.
  • Investment aligns with company's long-term expansion and growth strategy.
  • Subject to definitive agreements and necessary regulatory approvals.